Northwest Biotherapeutics (NWBO) Short-term Investments (2014 - 2017)

Northwest Biotherapeutics' Short-term Investments history runs 4 years deep, the most recent figure standing at $397000.0 for Q1 2017.

• In Q1 2017, Short-term Investments fell 46.78% year-over-year to $397000.0; the TTM figure through Mar 2017 stood at $397000.0 (down 46.78% YoY), while the FY2016 annual figure was $685000.0, down 22.69% from the prior year.
• Short-term Investments for Q1 2017 stood at $397000.0, down from $685000.0 in the prior quarter.
• The five-year high for Short-term Investments was $1.0 million in Q2 2015, with the low at $397000.0 in Q1 2017.
• The 4-year median for Short-term Investments is $806000.0 (2014), against an average of $779400.0.
• The sharpest annual moves came in 2015 and 2017: Short-term Investments advanced 2.43% in 2015, then sank 46.78% in 2017.
• Northwest Biotherapeutics' Short-term Investments stood at $865000.0 in 2014, then advanced by 2.43% to $886000.0 in 2015, then decreased by 22.69% to $685000.0 in 2016, then plunged by 42.04% to $397000.0 in 2017.
• Business Quant data shows NWBO's Short-term Investments at $397000.0 in Q1 2017, $685000.0 in Q4 2016, and $685000.0 in Q3 2016.